Abstract
In the United States, prostate cancer is the most common cancer in men, with an estimated 220,000 cases diagnosed in 2015 [1]. With a percentage of involvement of more than 80 %, the bone represents the preferential site of metastases for this disease. As a consequence, patients experiencing advanced stage castration-resistant prostate cancer (CRPC) are at increased risk of developing skeletal-related events, including pathologic fractures and spinal cord compression [2].
Cite
CITATION STYLE
Bracarda, S., Hamzaj, A., & Andrikou, K. (2016). New frontiers in treatment. In Bone Metastases from Prostate Cancer: Biology, Diagnosis and Management (pp. 209–223). Springer International Publishing. https://doi.org/10.1007/978-3-319-42327-2_17
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
